Hypothalamic growth hormone-releasing hormone (GHRH) cell number is increased in human illness, but is not reduced in Prader-Willi syndrome or obesity

Clinical Endocrinology

Volumn 58, Issue 6, 2003, Pages 743-755

  Goldstone, Anthony P ^a,b   Unmehopa, Unga A ^a   Swaab, Dick F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR;

ACUTE DISEASE; ADULT; ARTICLE; AUTOPSY; CELL COUNT; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; INFANT; MALE; MEDIAN EMINENCE; NERVE CELL; OBESITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CELL COUNT; CHRONIC DISEASE; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INFANT; LINEAR MODELS; MALE; MIDDLE AGED; NEURONS; OBESITY; PRADER-WILLI SYNDROME; REGRESSION ANALYSIS; SUDDEN INFANT DEATH;

EID: 0038469984     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01788.x     Document Type: Article

References (57)

1. Ariyasu, H., Takaya, K., Tagami, T., Ogawa, Y., Hosoda, K., Akamizu, T., Suda, M., Koh, T., Natsui, K., Toyooka, S., Shirakami, G., Usui, T., Shimatsu, A., Doi, K., Hosoda, H., Kojima, M., Kangawa, K. & Nakao, K. (2001) Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. Journal of Clinical Endocrinology and Metabolism, 86, 4753-4758.
2. Asakawa, A, Inui, A., Kaga, T., Yuzuriha, H., Nagata, T, Fujimiya, M., Katsuura, G., Makino, S., Fujino, M.A. & Kasuga, M. (2001) A role of ghrelin in neuroendocrine and behavioral responses to stress m mice. Neuroendocrinology, 74, 143-147.
3. Baxter, R.C., Hawker, F.H., To, C., Stewart, P.M. & Holman, S.R. (1998) Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients. Growth Hormone and IGF Research, 8, 455-463.
4. Bloch, B., Baird, A., Ling, N. & Guillemin, R. (1986) Immunohistochemical evidence that growth hormone-releasing factor (GRF) neurons contain an amidated peptide derived from cleavage of the carboxyl-terminal end of the GRF precursor. Endocrinology, 118, 156-162.
5. de Boer, H., Blok, G.J. & van der Veen, E.A. (1995) Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews, 16, 63-86.
6. Bosio, L., Beccaria, L., Benzi, F., Sanzari, A. & Chiumello, G. (1999) Body composition during GH treatment in Prader-Labhardt-Willi syndrome. Journal of Pediatric and Endocrinological Metabolism, 12 (Suppl. 1), 351-353.
7. Burman, P., Ritzén, E.M. & Lindgren, A.C. (2001) Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocrine Reviews, 22, 787-799.
8. Carro, E., Seoane, L.M., Senaris, R., Considine, R.V., Casanueva, F.F. & Dieguez, C. (1998) Interaction between leptin and neuropeptide Y on in vivo growth hormone secretion. Neuroendocrinology, 68, 187-191.
9. Carroll, P.V. (1999) Protein metabolism and the use of growth hormone and insulin-like growth factor-I in the critically ill patient. Growth Hormone and IGF Research, 9, 400-413.
10. Cattaneo, L., De Gennaro, C., Zoli, M., Muller, E. & Cocchi, D. (1996) Characterization of the hypothalamo-pituitary-IGF-I axis in rats made obese by overfeeding. Journal of Endocrinology, 148, 347-353.
11. Catzeflis, C., Pierroz, D.D., Rohner-Jeanrenaud, F., Rivier, J.E., Sizonenko, P.C. & Aubert, M.L. (1993) Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats. Endocrinology, 132, 224-234.
12. Ciofi, P., Tramu, G. & Bloch, B. (1990) Comparative immunohistochemical study of the distribution of neuropeptide Y, growth hormone-releasing factor and the carboxyterminus of precursor protein GHRF in the human hypothalamic infundibular area. Neuroendocrinology, 51, 429-436.
13. Cogan, J.D. & Phillips, J.A. (1998) Growth disorders caused by genetic defects in the growth hormone pathway. Advances in Pediatrics, 45, 337-361.
14. Corrias, A., Bellone, J., Beccaria, L., Bosio, L., Trifiro, G., Livieri, C., Ragusa, L., Salvatoni, A., Andreo, M., Ciampalini, P., Tonini, G. & Crino, A. (2000) GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology. Journal of Endocrinological Investigations, 23, 84-89.
15. Cummings, D.E., Clement, K., Purnell, J.Q., Vaisse, C., Foster, K.E., Frayo, R.S., Schwartz, M.W., Basdevant, A. & Weigle, D.S. (2002) Elevated plasma ghrelin levels in Prader-Willi syndrome. Nature Medicine, 8, 643-644.
16. Delparigi, A., Tschop, M., Heiman, M.L., Salbe, A.D., Vozarova, B., Sell, S.M., Bunt, J.C. & Tataranni, P.A. (2002) High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. Journal of Clinical Endocrinology and Metabolism, 87, 5461-5464.
17. Eiholzer, U., Bachmann, S. & l'Allemand, D. (2000) Is there growth hormone deficiency in Prader-Willi syndrome? Six arguments to support the presence of hypothalamic growth hormone deficiency in Prader-Willi syndrome. Hormone Research, 53 (Suppl. 3), 44-52.
18. Erickson, J.C., Hollopeter, G. & Palmiter, R.D. (1996) Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science, 274, 1704-1707.
19. Gabreëls, B.A., Swaab, D.F., Seidah, N.G., van Duijnhoven, H.L., Martens, G.J. & van Leeuwen, F.W. (1994) Differential expression of the neuroendocrine polypeptide 7B2 in hypothalami of Prader-(Labhart)-Willi syndrome patients. Brain Research, 657, 281-293.
20. Gabreëls, B.A.T.F., Swaab, D.F., deKleijn, D.P.V., Seidah, N.G., Van de Loo, J.W., Van de Ven, W.J.M., Martens, G.J.M. & van Leeuwen, F.W. (1998) Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: Indications for a processing defect. Journal of Clinical Endocrinology and Metabolism, 83, 591-599.
21. Ge, F., Tsagarakis, S., Rees, L.H., Besser, G.M. & Grossman, A. (1989) Relationship between growth hormone-releasing hormone and somatostatin in the rat: effects of age and sex on content and in vitro release from hypothalamic explants. Journal of Endocrinology, 123, 53-58.
22. Giustina, A. & Veldhuis, J.D. (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Reviews, 19, 717-797.
23. Goldstone, A.P., Unmehopa, U.A., Bloom, S.R. & Swaab, D.F. (2002) Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects. Journal of Clinical Endocrinology and Metabolism, 87, 927-937.
24. Grugni, G., Guzzaloni, G., Moro, D., Bettio, D., DeMedici, C. & Morabito, F. (1998) Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome. Clinical Endocrinology, 48, 769-775.
25. Hansen, T.K., Dall, R., Hosoda, H., Kojima, M., Kangawa, K., Christiansen, J.S. & Jorgensen, J.O. (2002) Weight loss increases circulating levels of ghrelin in human obesity. Clinical Endocrinology, 56, 203-206.
26. Haqq, A.M., Purnell, J.Q., Rosenfeld, R.G., Pratt, K.L., Tjoeng, E. & LaFranchi, S.H. (2002) Serum ghrelin levels are markedly increased in children with Prader-Willi syndrome (PWS). Abstracts 84th Annual Meeting Endocrine Society, San Francisco, OR23-6.
27. Hisano, S., Tsuruo, Y., Kagotani, Y., Daikoku, S. & Chihara, K. (1990) Immunohistochemical evidence for synaptic connections between neuropeptide Y-containing axons and periventricular somatostatin neurons in the anterior hypothalamus in rats. Brain Research, 520, 170-177.
28. Holm, V.A., Cassidy, S.B., Butler, M.G., Hanchett, J.M., Greenswag, L.R., Whitman, B.Y. & Greenberg, F. (1993) Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics, 91, 398-402.
29. Howard, A.D., Feighner, S.D., Cully, D.F., Arena, J.P., Liberator, P.A., Rosenblum, C.I., Hamelin, M., Hreniuk, D.L., Palyha, O.C., Anderson, J., Paress, P.S., Diaz, C., Chou, M., Liu, K.K., McKee, K.K., Pong, S.S., Chaung, L.Y., Elbrecht, A., Dashkevicz, M., Heavens, R., Rigby, M., Sirinathsinghji, D.J., Dean, D.C., Melillo, D.G. & Van der Ploeg, L.H. (1996) A receptor in pituitary and hypothalamus that functions in growth hormone release. Science, 273, 974-977.
30. Jessup, S.K., Dimaraki, E.V., Symons, K.V. & Barkan, A.L. (2002) Endogenous growth hormone-releasing hormone maintains basal growth hormone in women but not in men. Abstracts 84th Annual Meeting Endocrine Society, San Francisco, OR38-1.
31. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H. & Kangawa, K. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656-660.
32. Korbonits, M., Bustin, S.A., Kojima, M., Jordan, S., Adams, E.F., Lowe, D.G., Kangawa, K. & Grossman, A.B. (2001) The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. Journal of Clinical Endocrinology and Metabolism, 86, 881-887.
33. Kruijver, F.P., Fernandez-Guasti, A., Fodor, M., Kraan, E.M. & Swaab, D.F. (2001) Sex differences in androgen receptors of the human mamillary bodies are related to endocrine status rather than to sexual orientation or transsexuality. Journal of Clinical Endocrinology and Metabolism, 86, 818-827.
34. Loche, S., Pintor, C., Cappa, M., Ghigo, E., Puggioni, R., Locatelli, V. & Mnller, E.E. (1989) Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children. Acta Endocrinologica, 120, 624-628.
35. Lu, S., Guan, J.L., Wang, Q.P., Uehara, K., Yamada, S., Goto, N., Date, Y., Nakazato, M., Kojima, M., Kangawa, K. & Shioda, S. (2001) Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neuroscience Letters, 321, 157-160.
36. Maccario, M., Grottoli, S., Procopio, M., Oleandri, S.E., Rossetto, R., Gauna, C., Arvat, E. & Ghigo, E. (2000) The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors. International Journal of Obesity, 24 (Suppl. 2), S96-S99.
37. Mayer, A., Lahr, G., Swaab, D.F., Pilgrim, C. & Reisert, I. (1998) The Y-chromosomal genes SRY and ZFY are transcribed in adult human brain. Neurogenetics, 1, 281-288.
38. Merchenthaler, I., Vigh, S., Schally, A.V. & Petrusz, P. (1984) Immunocytochemical localization of growth hormone-releasing factor in the rat hypothalamus. Endocrinology, 114, 1082-1085.
39. Nagaya, N., Uematsu, M., Kojima, M., Date, Y., Nakazato, M., Okumura, H., Hosoda, H., Shimizu, W., Yamagishi, M., Oya, H., Koh, H., Yutani, C. & Kangawa, K. (2001) Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation, 104, 2034-2038.
40. Nicholls, R.D., Saitoh, S. & Horsthemke, B. (1998) Imprinting in Prader-Willi and Angelman syndromes. Trends in Genetics, 14, 194-200.
41. Nordmann, Y., Eiholzer, U., l'Allemand, D., Mirjanic, S. & Markwalder, C. (2002) Sudden death of an infant with Prader-Willi syndrome - not a unique case? Biology Neonate, 82, 139-141.
42. Ravid, R., Van Zwieten, E.J. & Swaab, D.F. (1992) Brain banking and the human hypothalamus: factors to match for, pitfalls and potentials. Progress in Brain Research, 93, 83-95.
43. Rittmaster, R.S., Loriaux, D.L. & Merriam, G.R. (1987) Effect of continuous somatostatin and growth hormone-releasing hormone (GHRH) infusions on the subsequent growth hormone (GH) response to GHRH. Evidence for somatotroph desensitization independent of GH pool depletion. Neuroendocrinology, 45, 118-122.
44. Russell, A., Jaffe, C.A., Demott, F. & Barkan, A.L. (1999) In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in aging. Journal of Clinical Endocrinology and Metabolism, 84, 3490-3497.
45. Sato, M. & Frohman, L.A. (1993) Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. Endocrinology, 133, 793-799.
46. van der Sluis, P.J., Pool, C.W. & Sluiter, A.A. (1987) Press-blotting on gelatin-coated nitrocellulose membranes. A method for sensitive quantitative immunodetection of peptides after gel isoelectric focusing. Journal of Immunological Methods, 104, 65-71.
47. Swaab, D.F. (1997) Prader-Willi syndrome and the hypothalamus. Acta Paediatrica Supplement, 423, 50-54.
48. Swaab, D.F., Purba, J.S. & Hofman, M.A. (1995) Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. Journal of Clinical Endocrinology and Metabolism, 80, 573-579.
49. Tschop, M., Weyer, C., Tataranni, P.A., Devanarayan, V., Ravussin, E. & Heiman, M.L. (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes, 50, 707-709.
50. Uchiyama, T., Kaji, H., Abe, H. & Chihara, K. (1994) Negative regulation of hypothalamic growth hormone-releasing factor messenger ribonucleic acid by growth hormone and insulin-like growth factor I. Neuroendocrinology, 59, 441-450.
51. Van den Berghe, G. (2000) Novel insights into the neuroendocrinology of critical illness. European Journal of Endocrinology, 143, 1-13.
52. Van den Berghe, G., de Zegher, F., Bowers, C.Y., Wouters, P., Muller, P., Soetens, F., Vlasselaers, D., Schetz, M., Verwaest, C., Lauwers, P. & Bouillon, R. (1996) Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness. Clinical Endocrinology, 45, 341-351.
53. Van den Berghe, G., de Zegher, F. & Bouillon, R. (1998) Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. Journal of Clinical Endocrinology and Metabolism, 83, 1827-1834.
54. Van den Berghe, G., Baxter, R.C., Weekers, F., Wouters, P, Bowers, C.Y. & Veldhuis, J.D. (2000) A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. Journal of Clinical Endocrinology and Metabolism, 85, 183-192.
55. Vance, M.L., Kaiser, D.L., Rivier, J., Vale, W. & Thorner, M.O. (1986) Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH. Journal of Clinical Endocrinology and Metabolism, 62, 591-594.
56. Weekers, F., Van Herck, E., Coopmans, W., Michalaki, M., Bowers, C.Y., Veldhuis, J.D. & Van den Berghe, G. (2002) A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. Endocrinology, 143, 764-774.
57. Whittington, J.E., Holland, A.J., Webb, T., Buffer, J., Clarke, D. & Boer, H. (2001) Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. Journal of Medical Genetics, 38, 792-798.